Long-Term Care Guidelines Following HCT
Complications from hematopoietic cell transplantation (HCT) can develop long after a patient leaves the transplant center. To prevent late complications from increasing morbidity in these patients, awareness of the specialized care these patients require is essential.
6 Month, 12 Month, and Annual Care Guidelines
In 2012, experts from seven international transplant professional societies published Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation , which outlines long-term screening and preventive practice guidelines applicable to both autologous and allogeneic transplant recipients. [ 1 ]
We offer these guidelines in user-friendly, portable formats for clinicians and patients. The guidelines are organized by organ system to assist in patient care planning and include:
- Complications and tests
- Preventive measures for 6 month, 12 month and annual appointments
- Recommendations for special populations including patients with GVHD, ongoing significant corticosteroid exposure, pediatric patients, and patients who have received total body irradiation (TBI)
Access HCT Guidelines for Clinicians
- Access interactive tool for a customizable list of screening recommendations
- View Long-Term Care Guidelines (PDF)
- Order print version or download the HCT Guidelines mobile app
Access Patient Post-Transplant Care Guidelines
Reference
- Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation; Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT) and Sociedade Brasileira de Transplante de Medula Ossea (SBTMO). Co-published in Biol Blood Marrow Transplant, 2012, 18(3): 348-371; Bone Marrow Transplant, 2012, 47(3): 337-341; and Hematol Oncol Stem Cell Ther, 2012, 5(1): 1-30. Access